Your browser doesn't support javascript.
loading
Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum.
Ameri, A H; Mooradian, M J; Emerick, K S; Park, J C; Wirth, L J; Asgari, M M; Tsao, H; Lawrence, D; Sullivan, R J; Demehri, S.
Afiliación
  • Ameri AH; Center for Cancer Immunology and Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, U.S.A.
  • Mooradian MJ; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, U.S.A.
  • Emerick KS; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, U.S.A.
  • Park JC; Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 02114, U.S.A.
  • Wirth LJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, U.S.A.
  • Asgari MM; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, U.S.A.
  • Tsao H; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, U.S.A.
  • Lawrence D; Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, U.S.A.
  • Sullivan RJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, U.S.A.
  • Demehri S; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, U.S.A.
Br J Dermatol ; 181(5): 1095-1097, 2019 11.
Article en En | MEDLINE | ID: mdl-31102460

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Xerodermia Pigmentosa / Carcinoma de Células Escamosas / Antineoplásicos Inmunológicos / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Etiology_studies Idioma: En Revista: Br J Dermatol Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Xerodermia Pigmentosa / Carcinoma de Células Escamosas / Antineoplásicos Inmunológicos / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Etiology_studies Idioma: En Revista: Br J Dermatol Año: 2019 Tipo del documento: Article